YENOM NOTICIAS
Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
Investing.com-- Guggenheim named Zura Bio a top pick in the biotechnology sector, reiterating its Buy rating and $20 price target ahead of the company's Phase II TibuSHIELD readout in hidradenitis suppurativa, expected in the fourth quarte…
On August 11, Zura Bio (NASDAQ:ZURA) reported second-quarter results that landed on an unusual mix of good and bad news. The clinical-stage biotech finished enrolling two separate Phase 2 studies of its lead drug, tibulizumab, both ahead o…
Zura Bio Limited (NASDAQ:ZURA) is one of the 10 High Growth Stocks Insiders Are Buying. On July 8, 2026, William Blair initiated coverage of Zura Bio Limited (NASDAQ:ZURA) with an Outperform rating. The firm sees potential for the dual mec…
(RTTNews) - Tenaya Therapeutics, Inc. (TNYA), a clinical-stage biotechnology company, announced the appointment of Eric Hyllengren as Chief Financial Officer, effective July 13, 2026, following the planned retirement of Hiro Higa, Senior V…
HENDERSON, Nev., May 13, 2026--(BUSINESS WIRE)--Zura Bio Limited (Nasdaq: ZURA) ("Zura"), a clinical-stage biotechnology company developing novel and differentiated medicines to meaningfully improve the lives of patients with serious and d…
* Zura Bio press release [https://seekingalpha.com/pr/20505301-zura-bio-reports-first-quarter-2026-financial-results-and-recent-corporate-updates] (ZURA [https://seekingalpha.com/symbol/ZURA]): Q1 GAAP EPS of -$0.22. * Cash and cash equiva…
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities. Continue Reading
As the United States market experiences fluctuations, with technology shares weighing on major indices like the Nasdaq, investors are closely monitoring economic indicators and Federal Reserve actions. In this context, penny stocks—often s…
With strong three-month performance and significant upside potential, Zura Bio Limited (NASDAQ:ZURA) secures a spot on our list of the 12 hot penny stocks to invest in right now.Bullish Outlook on Zura Bio Limited (ZURA) Amid Tibulizumab P…
As U.S. stock indexes hit record highs amid optimism over trade discussions between the U.S. and China, investors are increasingly looking for opportunities beyond the major indices. Penny stocks, often associated with smaller or newer com…
(RTTNews) - Biotech stocks led the after-hours charge on Thursday, with Inhibrx Biosciences (INBX) skyrocketing over 81% on positive Phase 2 trial results in chondrosarcoma. Femasys (FEMY), Cingulate (CING), and Community Health Systems (C…
[Ceo sign on wooden elements. Ceo Concept.close up of wooden elements,Business Concept.3D rendering on blue background.] fengdr/iStock via Getty Images * Zura Bio (NASDAQ:ZURA [https://seekingalpha.com/symbol/ZURA]) announced that its Chie…
Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Akero Therapeutics Inc (Symbol: AKRO), where a total of 8,313 contracts have traded so far, representing approximately 831,300 und…
As U.S. markets navigate a rebound with the Nasdaq and S&P 500 rising, investors are keeping a close eye on potential government shutdowns and economic shifts. Amid these broader market movements, penny stocks continue to capture interest…
As the U.S. market navigates a period of volatility marked by tech stock declines and fluctuating indices, investors are keenly watching for opportunities that might offer stability amidst uncertainty. Penny stocks, though an older term, s…
Investing.com - Oppenheimer lowered its price target on Zura Bio Ltd. (NASDAQ:ZURA) to $16.00 from $17.00 on Thursday, while maintaining an Outperform rating on the stock. The new target remains significantly above the current trading pric…
* Zura Bio press release [https://seekingalpha.com/pr/20201018-zura-bio-reports-second-quarter-2025-financial-results-and-recent-corporate-updates] (NASDAQ:ZURA [https://seekingalpha.com/symbol/ZURA]): Q2 GAAP EPS of -$0.17. * Reported $15…
Over the last 7 days, the market has remained flat, while in the past 12 months it has risen by 14%, with earnings expected to grow by 15% per annum over the next few years. For investors willing to explore beyond established names, penny…
Zura Bio (NASDAQ:ZURA [https://seekingalpha.com/symbol/ZURA]) has announced the appointment [https://seekingalpha.com/pr/20152922-zura-bio-announces-chief-financial-officer-transition] of Eric Hyllengren as CFO, effective July 7, 2025. He…
HENDERSON, Nev. - Zura Bio Limited (NASDAQ:ZURA) announced Tuesday that Eric Hyllengren will become its new Chief Financial Officer on July 7, 2025. Hyllengren will replace current CFO Verender Badial, who will remain with the company as a…
Sagimet Biosciences Inc. SAN MATEO, Calif., Aug. 01, 2024 (GLOBE NEWSWIRE) -- Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors designed to t…
Undervalued biotech stocks will always be relevant for the savvy investor. The biotech world is evolving rapidly, with pharmaceutical giants tirelessly building on their pipelines and technologies. We’re seeing gene editing become more ref…
There’s always a strong case for undervalued biotech stocks. For one, the industry is only expected to grow. In fact, according to Grand View Research, biotech could be worth about $3.88 trillion by 2030. After all, there’s always going to…
SAN DIEGO, March 27, 2023--(BUSINESS WIRE)--As previously announced on March 21, 2023, Zura Bio Limited ("Zura"), a multi-asset clinical-stage biotechnology company focused on developing novel medicines for immune and inflammatory disorder…